Fcpm Iii Services B.v.

Latest statistics and disclosures from Fcpm Iii Services B.v.'s latest quarterly 13F-HR filing:

  • Top 5 stock holdings are NAMS, MPLT, DYN, VOR, DMRA, and represent 83.71% of Fcpm Iii Services B.v.'s stock portfolio.
  • Added to shares of these 1 stock: AURA (+$29M).
  • Started 1 new stock position in AURA.
  • Reduced shares in these 2 stocks: NAMS (-$24M), DYN (-$18M).
  • Fcpm Iii Services B.v. was a net seller of stock by $-13M.
  • Fcpm Iii Services B.v. has $750M in assets under management (AUM), dropping by 3.91%.
  • Central Index Key (CIK): 0002013410

Tip: Access up to 7 years of quarterly data

Positions held by Fcpm Iii Services B.v. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Fcpm Iii Services B.v.

Fcpm Iii Services B.v. holds 11 positions in its portfolio as reported in the June 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Newamsterdam Pharma Company Ordinary Shares (NAMS) 38.3 $288M -7% 8.5M 33.89
 View chart
Maplight Therapeutics (MPLT) 15.4 $116M 3.2M 35.84
 View chart
Dyne Therapeutics (DYN) 11.4 $86M -17% 3.8M 22.21
 View chart
Vor Biopharma Com New (VOR) 10.1 $76M 4.1M 18.41
 View chart
Damora Therapeutics Com New (DMRA) 8.5 $64M 2.4M 26.01
 View chart
Replimune Group (REPL) 4.1 $31M 2.8M 11.07
 View chart
Crescent Biopharma (CBIO) 4.0 $30M 1.7M 18.00
 View chart
Aura Biosciences (AURA) 3.8 $29M NEW 4.1M 7.10
 View chart
Engene Holdings 2.2 $17M 9.6M 1.73
 View chart
Bicycle Therapeutics Sponsored Ads (BCYC) 2.0 $15M 3.5M 4.24
 View chart
Engene Holdings W Exp 10/31/2028 (ENGNW) 0.1 $834k 2.9M 0.29
 View chart

Past Filings by Fcpm Iii Services B.v.

SEC 13F filings are viewable for Fcpm Iii Services B.v. going back to 2023